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TO THE EDITOR
Peeling skin syndrome (PSS) refers to a
heterogeneous group of disorders char-
acterized by superficial detachment of
the epidermal corneal layers (Hacham-
Zadeh and Holubar, 1985). Two major
forms of PSS have been recognized:
acral PSS (MIM609796), caused by
mutations in TGM5, encoding transglu-
taminase 5 (Cassidy et al., 2005; Kharfi
et al., 2009), and generalized PSS
(MIM270300), which has been subclas-
sified into a noninflammatory type (type
A PSS), the etiology of which remains
unknown, and an inflammatory type
(type B), which was recently shown to
be associated in a large family with a
recessive mutation in CDSN, encoding
corneodesmosin (Oji et al., 2010).
In the present study, we report the
second mutation in CDSN underlying
type B PSS.
A 32-year-old man was referred
for investigation because of a congeni-
tal pruritic and generalized rash. The
patient was of Jewish origin, and his
parents were first-degree cousins. A
younger sister displayed similar derma-
tological findings (Figure 1a). The pa-
tient said that 3 days after his birth,
widespread reddish, peeling skin areas
had appeared over his legs, arms, and
trunk, along with redness and edema of
the face. The rash has been present ever
since, with rare periods of mild im-
provement, mainly in the spring (Figure
1b and c). From the age of 10, his nails
have been thick and yellowish.
Complete blood cell count and
blood chemistry were within normal
ranges, but IgE levels were markedly
elevated (30,375 IUml1; N¼ 0–100).
Fungal cultures from nail scrapings
were negative. Hair microscopy rev-
ealed normal hair shaft structures. A skin
biopsy showed mild hyperkeratosis,
parakeratosis, intracorneal and sub-
corneal separation, hypergranulosis, and
acanthosis. In the dermis, a perivascular
mononuclear infiltrate and scattered
eosinophils were seen (Figure 1d).
The patient provided written and
informed consent according to a proto-
col approved by the local Helsinki
Committee and by the Committee for
Genetic Studies of the Israeli Ministry of
Health. DNA was extracted from per-
ipheral blood leukocytes using the salt/
chloroform extraction method. Biologi-
cal materials were unavailable from the
patient’s family members. Genomic
DNA was PCR-amplified using primer
pairs spanning the entire coding se-
quence as well as intron–exon bound-
aries of the CDSN gene as described
elsewhere (Oji et al., 2010).
A homozygous single-nucleotide de-
letion was identified in exon 2 at
nucleotide position 743 (accession
number NC_000000.11) (Figure 1e).
The mutation, termed c.746delG, is
predicted to lead to frame shift and
to generate a premature stop codon
40 bp downstream of the deletion
(p.G249VfsX40). The mutation can be
predicted to result either in the synth-
esis of a truncated corneodesmosin
protein or in messenger RNA transcript
decay. We confirmed the presence of
the mutation in the patient’s DNA
sequence using a PCR–restriction frag-
ment length polymorphism assay,
whereby a 183-bp-long DNA fragment
was amplified using mutation-specific
forward primer 50-CCCCTACATCCCC
AGCTCCCACTCTGTGAC-30 and reverse
primer 50-ACCTCGTAGCCACCATAG
GA-30 (Figure 1f). Mutation c.746delG
abolishes a recognition site for DNA
endonucleases AhdI. We also used this
allele-specific PCR–restriction fragment
length polymorphism assay to exclude
the presence of the mutation in a panel of
50 population-matched control subjects.
Superficial intraepidermal detach-
ment has been described in a number
of inherited disorders, including ichthy-
osis bullosa of Siemens (Rothnagel
et al., 1994), epidermolysis bullosa sim-
plex superficialis (Fine et al., 1989),
Netherton syndrome (Geyer et al.,
2005), and PSS. Recently, a mutation
in CDSN, encoding corneodesmosin,
was found to segregate with PSS type B
(Oji et al., 2010) in a large Roma
family. In the present study, we report
the second pathogenic mutation in
CDSN, thus confirming the causative
role of these mutations in the pathogen-
esis of inflammatory PSS.
CDSN codes for corneodesmosin, a
secreted glycoprotein that is a compo-
nent of the modified desmosomal
plaques in the uppermost layers of the
epidermis. Corneodesmosin molecules
have been shown to interact through
their glycine loop domains in a homo-
philic fashion to mediate adhesive
interactions between corneocytes
(Jonca et al., 2002). Corneodesmosin
has also been shown to be expressed in
the inner root sheath of hair follicles
(Gallinaro et al., 2004). CDSN muta-
tions have previously been associated
with autosomal dominant hypotrichosis
simplex (MIM146520) (Levy-Nissen-
baum et al., 2003). In this disease the
mutant corneodesmosin was found to
exert a toxic effect on hair follicles via
the formation of amyloidosis deposits
(Caubet et al., 2010). Polymorphisms in
the CDSN gene have also been found in
association with psoriasis (Tazi Ahnini
et al., 1999). More recently, ablation of
CDSN in mice was found to result in
lethal epidermal permeability disrup-
tion (Matsumoto et al., 2008; Leclerc
et al., 2009), in line with similar data
obtained with ablation of another
component of the epidermal barrier,
filaggrin (Fallon et al., 2009).
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In the present study, we confirm the
association between the PSS type B
phenotype and deleterious mutations
in CDSN. Interestingly, our patient was
initially diagnosed with Netherton syn-
drome, a recessive disorder caused
by loss-of-function mutations in SPINK5
(Chavanas et al., 2000). SPINK5 en-
codes a serine protease inhibitor,
called LEKTI, in the absence of which
corneodesmosin undergoes premature
degradation in the upper layers of the
stratum corneum (Yang et al., 2004).
Additional elements are likely to
have an important role in the interac-
tions between structural proteins in the
cornified layers of the epidermis
and proteases and their inhibitors, as
supported by the existence of patients
displaying clinical features suggestive
of PSS type B/Netherton syndrome
but without mutations in CDSN or
SPINK5 (our unpublished data). Alto-
gether, these recent data seem to
demarcate a group of disorders featur-
ing excessive/aberrant desquamation
due to increased proteolytic activity
and/or decreased expression of adhe-
sive proteins in the upper epidermal
layers.
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TO THE EDITOR
We read with great interest the recent
paper by Jiang et al. (2011). The authors
performed a meta-analysis of 15 case–-
control studies involving 6,362 subjects
to examine the association between the
TP53 Arg72Pro polymorphism and skin
cancer risk. The meta-analysis suggests
that the TP53 Arg72Pro polymorphism
may have little involvement in skin
cancer susceptibility. Nevertheless, I
have several concerns.
First, they concluded that the TP53
Arg72Pro polymorphism may have little
involvement in the pathogenesis of skin
cancer, regardless of type, including
melanoma, squamous cell carcinoma
(SCC), and basal cell carcinoma (BCC).
But their results are insufficient to
support the conclusion. In the meta-
analysis, only 3 (348 cases and 730
controls) of the 15 studies were con-
ducted in non-Caucasians. In addition,
although they did not observe the
association between the TP53 Arg72Pro
polymorphism and risk of melanoma,
SCC, and BCC in the subgroup analysis
according to subtypes of skin cancer,
the results may be unreliable owing
to the limited sample size (melanoma:
1,282 cases and 2,149 controls; SCC:
670 cases and 1,635 controls; BCC:
804 cases and 1,891 controls). There-
fore, the results of the meta-analysis
indicate that the TP53 Arg72Pro
polymorphism may have little involve-
ment in the pathogenesis of skin
cancer, mainly in Caucasians. Further
studies based on larger sample size
and stratified by subtypes of skin cancer
are still needed, especially in non-
Caucasians.
Second, there are some problems
with the methods. A meta-analysis
should encompass as much infor-
mation as possible. However, the
authors searched only for articles in
the Medline database using the
PubMed engine, and results were lim-
ited to papers published in the English
language. Hence, it is possible that
some studies that meet the inclusion
criteria were not included in the meta-
analysis. Database bias, language bias,
and publication bias may have distorted
the results of the meta-analysis. In
addition, although the genotype con-
trasts (Arg/Arg versus Pro/Pro, Arg/Pro
versus Pro/Pro, Arg/ArgþArg/Pro
versus Pro/Pro, Arg/Arg versus Arg/
Proþ Pro/Pro) were reported in the
article, the allele (Arg allele versus Pro
allele) contrast was not reported. It is
necessary to perform the allele contrast.
Finally, they should follow PRISMA
(Preferred Reporting Items for
Systematic Reviews and Meta-Analyses)
guidelines when reporting their
meta-methods research (Liberati et al.,
2009).
Third, the article has other short-
comings. The quality of the studies
in the meta-analysis was assessed
using the predefined scale for quality
assessment (Table 5 in the article).
But their quality scale omitted the
important factor of whether cases and
controls were matched by age and
gender. Lack of matching by age and
gender could result in bias in case–-
control studies. Also, to determine the
sources of the heterogeneity across
studies, the authors performed the
stratified analysis by subtypes of skin
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